Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.

Low-grade concern — timing, disclosure, or lab context

Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.

Mechanism and evidence

Case reports describe INR changes and bleeding with ginseng on anticoagulants; without a warfarin-style INR window on DOACs, the practical level stays low-caution. The cited anchor is the warfarin-by-ginseng interaction RCT; on DOACs the borrowing is class-level context, not a trial of this pair.

Evidence tier: mechanistic

The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.

What to discuss with your prescriber

  • Mention ginseng to your prescriber.
  • Report bruising or bleeding.

← All reviewed pairs for DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)